Bill Text: TX SB172 | 2015-2016 | 84th Legislature | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Relating to the addition of certain substances to Penalty Groups 1-A and 2 of the Texas Controlled Substances Act for criminal prosecution and other purposes.
Spectrum: Slight Partisan Bill (Republican 3-1)
Status: (Passed) 2015-05-22 - Effective on 9/1/15 [SB172 Detail]
Download: Texas-2015-SB172-Introduced.html
Bill Title: Relating to the addition of certain substances to Penalty Groups 1-A and 2 of the Texas Controlled Substances Act for criminal prosecution and other purposes.
Spectrum: Slight Partisan Bill (Republican 3-1)
Status: (Passed) 2015-05-22 - Effective on 9/1/15 [SB172 Detail]
Download: Texas-2015-SB172-Introduced.html
By: Huffman | S.B. No. 172 | |
|
||
|
||
relating to the addition of certain substances to Penalty Groups | ||
1-A and 2 of the Texas Controlled Substances Act for criminal | ||
prosecution and other purposes. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Subdivision (50), Section 481.002, Health and | ||
Safety Code, is amended to read as follows: | ||
(50) "Abuse unit" means: | ||
(A) except as provided by Paragraph (B): | ||
(i) a single unit on or in any adulterant, | ||
dilutant, or similar carrier medium, including marked or perforated | ||
blotter paper, a tablet, gelatin wafer, sugar cube, or stamp, or | ||
other medium that contains any amount of a controlled substance | ||
listed in Penalty Group 1-A, if the unit is commonly used in abuse | ||
of that substance; or | ||
(ii) each quarter-inch square section of | ||
paper, if the adulterant, dilutant, or carrier medium is paper not | ||
marked or perforated into individual abuse units; or | ||
(B) if the controlled substance is in liquid or | ||
solid form, 40 micrograms of the controlled substance including any | ||
adulterant or dilutant. | ||
SECTION 2. Section 481.1021, Health and Safety Code, is | ||
amended to read as follows: | ||
Sec. 481.1021. PENALTY GROUP 1-A. (a) Penalty Group 1-A | ||
consists of: | ||
(1) lysergic acid diethylamide (LSD), including its | ||
salts, isomers, and salts of isomers; and | ||
(2) compounds structurally derived from | ||
2,5-dimethoxyphenethylamine by substitution at the 1-amino | ||
nitrogen atom with a benzyl substituent, including: | ||
(A) compounds further modified by: | ||
(i) substitution in the phenethylamine ring | ||
at the 4- position to any extent (including alkyl, alkoxy, | ||
alkylenedioxy, haloalkyl, or halide substituents); or | ||
(ii) substitution in the benzyl ring to any | ||
extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or | ||
halide substituents); and | ||
(B) by example, compounds such as: | ||
4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl) | ||
phenethylamine (trade or other names: 25B-NBOMe, 2C-B-NBOMe); | ||
4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl) | ||
phenethylamine (trade or other names: 25C-NBOMe, 2C-C-NBOMe); | ||
2,5-Dimethoxy-4-methyl-N-(2-methoxybenzyl) | ||
phenethylamine (trade or other names: 25D-NBOMe, 2C-D-NBOMe); | ||
4-Ethyl-2,5-dimethoxy-N-(2-methoxybenzyl) | ||
phenethylamine (trade or other names: 25E-NBOMe, 2C-E-NBOMe); | ||
2,5-Dimethoxy-N-(2- | ||
methoxybenzyl)phenethylamine (trade or other names: 25H-NBOMe, | ||
2C-H-NBOMe); | ||
4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl) | ||
phenethylamine (trade or other names: 25I-NBOMe, 2C-I-NBOMe); | ||
4-Iodo-2,5-dimethoxy-N- | ||
benzylphenethylamine (trade or other name: 25I-NB); | ||
4-Iodo-2,5-dimethoxy-N-(2,3- | ||
methylenedioxybenzyl)phenethylamine (trade or other name: | ||
25I-NBMD); | ||
4-Iodo-2,5-dimethoxy-N-(2- | ||
fluorobenzyl)phenethylamine (trade or other name: 25I-NBF); | ||
4-Iodo-2,5-dimethoxy-N-(2-hydroxybenzyl) | ||
phenethylamine (trade or other name: 25I-NBOH); | ||
2,5-Dimethoxy-4-nitro-N-(2-methoxybenzyl) | ||
phenethylamine (trade or other names: 25N-NBOMe, 2C-N-NBOMe); and | ||
2,5-Dimethoxy-4-(n)-propyl-N-(2- | ||
methoxybenzyl)phenethylamine (trade or other names: 25P-NBOMe, | ||
2C-P-NBOMe). | ||
(b) To the extent Subsection (a)(2) conflicts with this | ||
subtitle or another law, the subtitle or other law prevails. | ||
SECTION 3. Subsections (a) and (c), Section 481.103, Health | ||
and Safety Code, are amended to read as follows: | ||
(a) Penalty Group 2 consists of: | ||
(1) any quantity of the following hallucinogenic | ||
substances, their salts, isomers, and salts of isomers, unless | ||
specifically excepted, if the existence of these salts, isomers, | ||
and salts of isomers is possible within the specific chemical | ||
designation: | ||
alpha-ethyltryptamine; | ||
alpha-methyltryptamine; | ||
[ |
||
|
||
|
||
[ |
||
Bufotenine (some trade and other names: 3-(beta- | ||
Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5- | ||
indolol; N, N-dimethylserotonin; 5-hydroxy-N, N- | ||
dimethyltryptamine; mappine); | ||
Diethyltryptamine (some trade and other | ||
names: N, N-Diethyltryptamine, DET); | ||
2, 5-dimethoxyamphetamine (some trade or other | ||
names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); | ||
[ |
||
|
||
[ |
||
|
||
Dimethyltryptamine (trade or other name: DMT); | ||
Dronabinol (synthetic) in sesame oil and | ||
encapsulated in a soft gelatin capsule in a U.S. Food and Drug | ||
Administration approved drug product (some trade or other names for | ||
Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- | ||
trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- | ||
(trans)- tetrahydrocannabinol); | ||
Ethylamine Analog of Phencyclidine (some trade or | ||
other names: N-ethyl-1-phenylcyclohexylamine, (1- | ||
phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, | ||
cyclohexamine, PCE); | ||
Ibogaine (some trade or other names: 7-Ethyl-6, | ||
6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- | ||
pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); | ||
Mescaline; | ||
5-methoxy-N, N-diisopropyltryptamine; | ||
5-methoxy-3, 4-methylenedioxy amphetamine; | ||
4-methoxyamphetamine (some trade or other | ||
names: 4-methoxy-alpha-methylphenethylamine; | ||
paramethoxyamphetamine; PMA); | ||
1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, | ||
PPMP); | ||
4-methyl-2, 5-dimethoxyamphetamine (some trade | ||
and other names: 4-methyl-2, 5-dimethoxy-alpha- | ||
methylphenethylamine; "DOM"; "STP"); | ||
3,4-methylenedioxy methamphetamine (MDMA, MDM); | ||
3,4-methylenedioxy amphetamine; | ||
3,4-methylenedioxy N-ethylamphetamine (Also | ||
known as N-ethyl MDA); | ||
Nabilone (Another name for nabilone: (+)-trans- | ||
3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, | ||
6-dimethyl-9H-dibenzo[b,d] pyran-9-one; | ||
N-benzylpiperazine (some trade or other | ||
names: BZP; 1-benzylpiperazine); | ||
N-ethyl-3-piperidyl benzilate; | ||
N-hydroxy-3,4-methylenedioxyamphetamine (Also | ||
known as N-hydroxy MDA); | ||
4-methylaminorex; | ||
N-methyl-3-piperidyl benzilate; | ||
Parahexyl (some trade or other names: 3-Hexyl-1- | ||
hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] | ||
pyran; Synhexyl); | ||
1-Phenylcyclohexylamine; | ||
1-Piperidinocyclohexanecarbonitrile (PCC); | ||
Psilocin; | ||
Psilocybin; | ||
Pyrrolidine Analog of Phencyclidine (some trade | ||
or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); | ||
Tetrahydrocannabinols, other than marihuana, and | ||
synthetic equivalents of the substances contained in the plant, or | ||
in the resinous extractives of Cannabis, or synthetic substances, | ||
derivatives, and their isomers with similar chemical structure and | ||
pharmacological activity such as: | ||
delta-1 cis or trans tetrahydrocannabinol, | ||
and their optical isomers; | ||
delta-6 cis or trans tetrahydrocannabinol, | ||
and their optical isomers; | ||
delta-3, 4 cis or trans | ||
tetrahydrocannabinol, and its optical isomers; | ||
compounds of these structures, regardless of | ||
numerical designation of atomic positions, since nomenclature of | ||
these substances is not internationally standardized; | ||
Thiophene Analog of Phencyclidine (some trade or | ||
other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl | ||
Analog of Phencyclidine; TPCP, TCP); | ||
1-pyrrolidine (some trade or other name: TCPy); | ||
1-(3-trifluoromethylphenyl)piperazine (trade or | ||
other name: TFMPP); and | ||
3,4,5-trimethoxy amphetamine; | ||
(2) Phenylacetone (some trade or other | ||
names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl | ||
ketone); | ||
(3) unless specifically excepted or unless listed in | ||
another Penalty Group, a material, compound, mixture, or | ||
preparation that contains any quantity of the following substances | ||
having a potential for abuse associated with a depressant or | ||
stimulant effect on the central nervous system: | ||
Aminorex (some trade or other | ||
names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- | ||
phenyl-2-oxazolamine); | ||
Amphetamine, its salts, optical isomers, and | ||
salts of optical isomers; | ||
Cathinone (some trade or other names: 2-amino-1- | ||
phenyl-1-propanone, alpha-aminopropiophenone, 2- | ||
aminopropiophenone); | ||
Etorphine Hydrochloride; | ||
Fenethylline and its salts; | ||
Lisdexamfetamine, including its salts, isomers, | ||
and salts of isomers; | ||
Mecloqualone and its salts; | ||
Methaqualone and its salts; | ||
Methcathinone (some trade or other names: 2- | ||
methylamino-propiophenone; alpha-(methylamino)propriophenone; | ||
2-(methylamino)-1-phenylpropan-1-one; alpha-N- | ||
methylaminopropriophenone; monomethylpropion; ephedrone, N- | ||
methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR | ||
1431); | ||
N-Ethylamphetamine, its salts, optical isomers, | ||
and salts of optical isomers; and | ||
N,N-dimethylamphetamine (some trade or other | ||
names: N,N,alpha-trimethylbenzeneethaneamine; | ||
N,N,alpha-trimethylphenethylamine), its salts, optical isomers, | ||
and salts of optical isomers; [ |
||
(4) any compound structurally derived from | ||
2-aminopropanal by substitution at the 1-position with any | ||
monocyclic or fused-polycyclic ring system, including: | ||
(A) compounds further modified by: | ||
(i) substitution in the ring system to any | ||
extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or | ||
halide substituents), whether or not further substituted in the | ||
ring system by other substituents; | ||
(ii) substitution at the 3-position with an | ||
alkyl substituent; or | ||
(iii) substitution at the 2-amino nitrogen | ||
atom with alkyl or dialkyl groups, or inclusion of the 2-amino | ||
nitrogen atom in a cyclic structure; and | ||
(B) by example, compounds such as: | ||
4-Methylmethcathinone (Also known as | ||
Mephedrone); | ||
3,4-Dimethylmethcathinone (Also known as | ||
3,4-DMMC); | ||
3-Fluoromethcathinone (Also known as 3-FMC); | ||
4-Fluoromethcathinone (Also known as | ||
Flephedrone); | ||
3,4-Methylenedioxy-N-methylcathinone (Also | ||
known as Methylone); | ||
3,4-Methylenedioxypyrovalerone (Also known | ||
as MDPV); | ||
alpha-Pyrrolidinopentiophenone (Also known | ||
as alpha-PVP); | ||
Naphthylpyrovalerone (Also known as | ||
Naphyrone); | ||
alpha-Methylamino-valerophenone (Also known | ||
as Pentedrone); | ||
beta-Keto-N-methylbenzodioxolylpropylamine | ||
(Also known as Butylone); | ||
beta-Keto-N-methylbenzodioxolylpentanamine | ||
(Also known as Pentylone); | ||
beta-Keto-Ethylbenzodioxolylbutanamine | ||
(Also known as Eutylone); and | ||
3,4-methylenedioxy-N-ethylcathinone (Also | ||
known as Ethylone); | ||
(5) 2,5-Dimethoxyphenethylamine and any compound | ||
structurally derived from 2,5-Dimethoxyphenethylamine by | ||
substitution at the 4-position of the phenyl ring to any extent | ||
(including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide | ||
substituents), including, by example, compounds such as: | ||
4-Bromo-2,5-dimethoxyphenethylamine (trade or | ||
other name: 2C-B); | ||
4-Chloro-2,5-dimethoxyphenethylamine (trade or | ||
other name: 2C-C); | ||
2,5-Dimethoxy-4-methylphenethylamine (trade or | ||
other name: 2C-D); | ||
4-Ethyl-2,5-dimethoxyphenethylamine (trade or | ||
other name: 2C-E); | ||
4-Iodo-2,5-dimethoxyphenethylamine (trade or | ||
other name: 2C-I); | ||
2,5-Dimethoxy-4-nitrophenethylamine (trade or | ||
other name: 2C-N); | ||
2,5-Dimethoxy-4-(n)-propylphenethylamine (trade | ||
or other name: 2C-P); | ||
4-Ethylthio-2,5-dimethoxyphenethylamine (trade | ||
or other name: 2C-T-2); | ||
4-Isopropylthio-2,5-dimethoxyphenethylamine | ||
(trade or other name: 2C-T-4); and | ||
2,5-Dimethoxy-4-(n)-propylthiophenethylamine | ||
(trade or other name: 2C-T-7); and | ||
(6) 2,5-Dimethoxyamphetamine and any compound | ||
structurally derived from 2,5-Dimethoxyamphetamine by substitution | ||
at the 4- position of the phenyl ring to any extent (including | ||
alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), | ||
including, by example, compounds such as: | ||
4-Ethylthio-2,5-dimethoxyamphetamine (trade or | ||
other name: Aleph-2); | ||
4-Isopropylthio-2,5-dimethoxyamphetamine (trade | ||
or other name: Aleph-4); | ||
4-Bromo-2,5-dimethoxyamphetamine (trade or other | ||
name: DOB); | ||
4-Chloro-2,5-dimethoxyamphetamine (trade or | ||
other name: DOC); | ||
2,5-Dimethoxy-4-ethylamphetamine (trade or other | ||
name: DOET); | ||
4-Iodo-2,5-dimethoxyamphetamine (trade or other | ||
name: DOI); | ||
2,5-Dimethoxy-4-methylamphetamine (trade or | ||
other name: DOM); | ||
2,5-Dimethoxy-4-nitroamphetamine (trade or other | ||
name: DON); | ||
4-Isopropyl-2,5-dimethoxyamphetamine (trade or | ||
other name: DOIP); and | ||
2,5-Dimethoxy-4-(n)-propylamphetamine (trade or | ||
other name: DOPR). | ||
(c) To the extent Subsection (a)(4), (5), or (6) conflicts | ||
with this subtitle or another law, the subtitle or other law | ||
prevails. | ||
SECTION 4. The change in law made by this Act applies only | ||
to an offense committed on or after the effective date of this Act. | ||
An offense committed before the effective date of this Act is | ||
governed by the law in effect on the date the offense was committed, | ||
and the former law is continued in effect for that purpose. For | ||
purposes of this section, an offense was committed before the | ||
effective date of this Act if any element of the offense occurred | ||
before that date. | ||
SECTION 5. This Act takes effect September 1, 2015. |